Skip to content
healthcare.dev

Loratadine and Pseudoephedrine

NDC 46122-383, loratadine and pseudoephedrine, tablet, extended release, from AMERISOURCE BERGEN.

Product NDC
46122-383
Status
Listed
Labeler
AMERISOURCE BERGEN
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA076557
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/46122-383 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LORATADINE10 mg/1
  • PSEUDOEPHEDRINE SULFATE240 mg/1

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
46122-383-224612203832215 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (46122-383-22)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 46122038322

    GET /v1/drugs/nadac/46122038322

Use it

Look up 46122-383 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/46122-383 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 46122-383. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.